▲ BUY
8
/ 10
Conviction
$ Value
$31K
Shares
10,000
Price
$3
Filed
Apr 1
▶ Why this score? (8/10)
- ✓ Open market buy (+3)
- ✓ % of holdings >= 20% (+2)
- ✓ C-suite insider (+2)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
WEAVER GREGORY L
Title
Chief Financial Officer
CIK
0001251779
Roles
Officer
Transaction Details
Transaction Date
2026-04-01
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
38,078
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.1450 to $3.1499, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Filing Info
WEAVER GREGORY L's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | ALT | ▲ | $31K ★ |
| 2026-02-26 | ALT | A | $0 |
| 2026-02-26 | ALT | A | $0 |
| 2025-11-11 | ALT | M | $0 |
| 2025-11-11 | ALT | F | $24K |
| 2025-11-11 | ALT | M | $0 |
| 2025-10-01 | ALT | A | $0 |
| 2025-10-01 | ALT | A | $0 |
Other Insiders at ALT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Durso Jerome Benedict
President and CEO
|
$47K | — | 2026-04-01 |
| GILL JOHN | $31K | — | 2026-04-06 |
|
WEAVER GREGORY L
Chief Financial Officer
|
— | — | 2026-02-26 |
| Garg Vipin K | — | — | 2026-01-31 |
|
Roberts M Scot
Chief Scientific Officer
|
— | — | 2026-02-26 |
|
Jordt Raymond M
Chief Business Officer
|
— | — | 2026-01-31 |